E. Björling

发表

CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates.

J. Albert, Å. Björndal, M. Jansson, 2002, AIDS research and human retroviruses.

Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.

E. Lucht, E. Björling, P. Skott, 2002, Oral diseases.

A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus

A. Plyusnin, Å. Lundkvist, E. Salonen, 2000, Journal of medical virology.

Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity.

B. Wahrén, B. Svennerholm, A. Vahlne, 1996, AIDS research and human retroviruses.

Cross-Protection against Challenge with Puumala Virus after Immunization with Nucleocapsid Proteins from Different Hantaviruses

A. Plyusnin, Å. Lundkvist, E. Björling, 2002, Journal of Virology.

Fine characterization of the antigenic site within the flap region in the protease protein of HIV-1

E. Björling, M. Ehnlund, 2000, Archives of Virology.

Immunoglobulin A responses to Puumala hantavirus.

Å. Lundkvist, E. Björling, C. de Carvalho Nicacio, 2000, The Journal of general virology.

Multiple Functions of Immunoglobulin A in Mucosal Defense against Viruses: an In Vitro Measles Virus Model

Huimin Yan, E. Björling, M. Lamm, 2002, Journal of Virology.

Potent Neutralizing Serum Immunoglobulin A (IgA) in Human Immunodeficiency Virus Type 2-Exposed IgG-Seronegative Individuals

P. Aaby, C. Nilsson, E. Björling, 2004, Journal of Virology.

Distinct Kinetics for Binding of the CD46 and SLAM Receptors to Overlapping Sites in the Measles Virus Hemagglutinin Protein*

Thilo Stehle, T. Stehle, J. Casasnovas, 2002, The Journal of Biological Chemistry.

Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection.

N. Taveira, C. Nilsson, E. Björling, 2003, Virology.

Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates, Like HIV-1 Isolates, Frequently Use CCR5 but Show Promiscuity in Coreceptor Usage

J. Albert, E. Fenyö, D. Littman, 1999, Journal of Virology.

Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein

F. Chiodi, E. Norrby, P. Stålhandske, 1991, Journal of virology.

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.

C. Barbas, F. Chiodi, E. Norrby, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.

J. Albert, F. Chiodi, E. Fenyö, 1993, Virology.

Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays.

J. Albert, E. Fenyö, G. Scarlatti, 1993, AIDS research and human retroviruses.

Immune Responses againstHIV-2

E. Björling, 2002 .

Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display.

M. Persson, A. Mörner, E. Björling, 1999, The Journal of general virology.

B-Cell Sites in the HIV Glycoproteins

E. Norrby, E. Björling, 1996 .

Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes.

J. Albert, T. Unge, J. Gronowitz, 2000, AIDS research and human retroviruses.

Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2.

R. Thorstensson, A. Mörner, M. Norin, 1999, Virus research.

Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2.

R. Thorstensson, M. Norin, E. Björling, 1999, Viral immunology.

B-cell Epitopes on the Envelope Glycoproteins of SIV and HIV-2

E. Björling, K. Kent, 1997 .

Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2.

F. Chiodi, E. Norrby, E. Björling, 1994, Journal of immunology.

Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.

F. Chiodi, E. Norrby, R. Thorstensson, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase

C. Boucher, F. Chiodi, E. Norrby, 1993, Journal of clinical microbiology.

Salivary sIgA response in HIV-1 infection.

J. Dillner, I. Julander, E. Lucht, 1999, Journal of acquired immune deficiency syndromes.

Neutralizing Human Fab Fragments against Measles Virus Recovered by Phage Display

Paul W. H. I. Parren, Dennis R. Burton, D. Burton, 2002, Journal of Virology.

Productive HIV-2 infection in the brain is restricted to macrophages/microglia

Á. McKnight, S. Lucas, A. Mörner, 2003, AIDS.

Cloning, expression, and purification of HIV-2 gp125

Adnane Achour, Robert A Harris, R. Harris, 2005, Molecular biotechnology.

Four distinct antigenic regions are present in the primary structure of HIV‐1 and HIV‐2 proteinases

F. Chiodi, E. Norrby, E. Björling, 1992, AIDS.

Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine.

F. Chiodi, E. Norrby, K. Lövgren, 1994, Journal of acquired immune deficiency syndromes.

Identification of four antibody‐binding sites in the envelope proteins of simian immunodeficiency virus, SIVsm

F. Chiodi, E. Norrby, E. Björling, 1993, AIDS.